InvestorsHub Logo
Followers 69
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: UCParadise post# 4348

Monday, 11/05/2018 7:35:33 PM

Monday, November 05, 2018 7:35:33 PM

Post# of 16729
Encore:

I agree with your observation (No FDA requirements). However, what I am also stating is there is no timeline for a device to be completed. It could be years down the road for all we know. Hell...just look @ Cannabix and also the line of failed attempts @ Breathtec thus far (POC FAIMS, Na-Nose, Zika). You can't simply dismiss the past if you're a long pre-split, sitting on half your shares now. This stock has become 100% riskier! A dip to 10 cent (pre-split price) now means half your value is further sucked into the Abyss. There is literally no room for error/continuous restarts at this point for longs. We have some idea of the repurposed drugs route as laid out for shareholoders in the recent news release. So, why can't management spell it out as best they can for common shareholders regarding a RUO device timeline? Simply more theories to come down the pike as time moves on >>>

We also do not have any idea of how big a "research" market would be for a RUO device. Are we also to believe management has no clue how big a target market that may be? Unfortunately, the only thing certain @ Breathtec is there will be more dilution as the years tic off. Management simply makes it too easy to be skeptical about Breathtec's future. Smoki says Breathtec needs "Bigger" news. Oh really? Like what news does anyone foresee coming down the pike anytime soon? They just gave us a Calendar Year 2019 accounting for Nash Pharmaceuticals. They have now stated unequivocally there are no 3rd Party agreements for FAIMS. Meaning, the Yost appointment with Owlstone has Jack Sh*t to do with common shareholders of Breathtec. Yost is off doing His Thing with His Buddies now. This is simply a long-term hold...and I mean loooog term.

Right or wrong...it's just my final opinion.

GL2ALL,

/////AMG



Red Pills